Bulk Pharmaceutical API Sources for ibuprofen sodium

Bulk Pharmaceutical API Sources for ibuprofen sodium

Vendor	Vendor Homepage	Vendor Sku	API Url
BenchChem		B1264696
THE BioTek		bt-1596796
CymitQuimica		CQ_527688-20-6
RR Scientific		R182369

Bulk Active Pharmaceutical Ingredient (API) Sources for Ibuprofen Sodium

Last updated: February 19, 2026

This report identifies key global manufacturers and supply chain considerations for bulk Ibuprofen Sodium API. The analysis focuses on production capacity, regulatory compliance, and geographical distribution of API suppliers to inform R&D and procurement strategies.

What is Ibuprofen Sodium API?

Ibuprofen Sodium is the sodium salt form of ibuprofen, a non-steroidal anti-inflammatory drug (NSAID) used to reduce fever and inflammation. It is formulated into various dosage forms, including tablets, capsules, and oral suspensions. The API is characterized by its chemical structure, purity standards, and physical properties, which are critical for pharmaceutical manufacturing.

Chemical Structure and Properties

Ibuprofen Sodium has the chemical formula C13H17NaO2. It is a white to off-white crystalline powder. Key properties relevant to API sourcing include:

• Solubility: Readily soluble in water, facilitating faster absorption compared to ibuprofen acid.
• Stability: Requires controlled storage conditions to maintain efficacy and prevent degradation.
• Purity: Must meet stringent pharmacopeial standards (e.g., USP, EP, JP) for heavy metals, residual solvents, and related substances.

Regulatory Landscape

The production and supply of Ibuprofen Sodium API are governed by regulatory bodies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other national health authorities. Compliance with Good Manufacturing Practices (GMP) is mandatory for all API manufacturers. Key regulatory aspects include:

• Drug Master Files (DMFs): Manufacturers typically maintain DMFs with regulatory agencies, detailing manufacturing processes, quality control, and site information.
• Inspections: Facilities are subject to regular inspections by regulatory authorities and pharmaceutical clients to ensure ongoing compliance.
• Certifications: Obtaining Certificates of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) is a common benchmark for European market access.

Global Manufacturers of Ibuprofen Sodium API

The global supply of Ibuprofen Sodium API is concentrated among a limited number of manufacturers, primarily located in Asia and Europe. These entities possess the necessary infrastructure, technical expertise, and regulatory approvals to produce pharmaceutical-grade API.

Key Manufacturing Regions and Companies

Several companies are recognized for their significant production capacity and established market presence in Ibuprofen Sodium API:

• China: This region is a dominant force in API manufacturing due to cost advantages and high production volumes.

  • Qilu Pharmaceutical Co., Ltd.: A major pharmaceutical group with substantial API production capabilities.
  • Hengdian Group: Known for its diversified pharmaceutical holdings, including API manufacturing.
  • Zhejiang NHU Co., Ltd.: A significant player in the chemical and pharmaceutical intermediates sector.
  • Lvyuan Pharmaceutical: Another established Chinese API producer.

• India: India is a global leader in generic drug and API manufacturing, renowned for its quality and competitive pricing.

  • IOL Chemicals and Pharmaceuticals Ltd.: One of the largest producers of ibuprofen globally, with significant capacity for ibuprofen sodium.
  • Granules India Ltd.: A significant manufacturer of pharmaceutical intermediates and APIs.
  • Divi's Laboratories: While primarily known for other APIs, they have a broad manufacturing base.

• Europe: European manufacturers often focus on high-purity grades and adherence to stringent regulatory standards.

  • BASF SE (Germany): A global chemical company with a pharmaceutical ingredients division. While their primary ibuprofen API is the acid form, they are a potential supplier or partner.
  • Recordati S.p.A. (Italy): Known for its pharmaceutical products and API manufacturing capabilities.

Production Capacity and Scale

Production capacity for Ibuprofen Sodium API varies significantly among manufacturers. Major players often operate multiple production lines and sites to meet global demand. Specific capacity figures are proprietary, but industry estimates suggest:

• Global Capacity: The total global capacity for ibuprofen and its salts is estimated to be in the tens of thousands of metric tons annually.
• Key Supplier Capacity: Leading manufacturers like IOL Chemicals and Pharmaceuticals Ltd. have reported annual production capacities for ibuprofen exceeding 12,000 metric tons, with a significant portion allocated to various salt forms.

Table 1: Overview of Ibuprofen Sodium API Manufacturers

Company Name	Country	Primary Focus Areas	Key Certifications/Approvals
IOL Chemicals and Pharmaceuticals Ltd.	India	Ibuprofen, Ibuprofen Sodium, APIs, Intermediates	US FDA, EDQM, WHO-GMP
Qilu Pharmaceutical Co., Ltd.	China	APIs, Finished Dosage Forms	US FDA, EDQM (through group)
Hengdian Group	China	APIs, Specialty Chemicals, Healthcare	US FDA, EDQM (through group)
Zhejiang NHU Co., Ltd.	China	Vitamins, APIs, Specialty Chemicals	US FDA, EDQM (through group)
Granules India Ltd.	India	APIs, Pharmaceutical Intermediates	US FDA, EDQM, WHO-GMP
BASF SE	Germany	Chemicals, Materials, Pharmaceuticals	US FDA, EMA (for ibuprofen acid)
Recordati S.p.A.	Italy	APIs, Pharmaceuticals	EMA, US FDA (through group)

Note: Certifications listed are indicative; specific product filings and site approvals should be verified.

Supply Chain Dynamics and Considerations

The Ibuprofen Sodium API supply chain is subject to several factors influencing availability, cost, and quality. Understanding these dynamics is crucial for risk mitigation and strategic sourcing.

Geographic Concentration and Risk Factors

The heavy concentration of API manufacturing in China and India presents both opportunities and risks:

• Geopolitical Risks: Trade tensions, export restrictions, or political instability in major manufacturing regions can disrupt supply.
• Environmental Regulations: Increasingly stringent environmental regulations in China have led to temporary plant shutdowns or increased compliance costs, impacting production output and pricing.
• Logistics: Global shipping disruptions, port congestion, and rising freight costs can affect lead times and overall cost of goods.
• Pandemic Impacts: As demonstrated by recent global events, public health crises can severely impact manufacturing operations and international transport.

Quality Control and Assurance

Ensuring the consistent quality of Ibuprofen Sodium API is paramount for patient safety and product efficacy. Pharmaceutical companies must implement robust quality assurance processes:

• Supplier Audits: Regular on-site audits of API manufacturers are essential to verify GMP compliance, quality management systems, and process control.
• Batch Testing: Independent testing of incoming API batches by the purchasing company or a third-party laboratory is critical to confirm specifications.
• Regulatory Filings: Verification of up-to-date DMFs and regulatory approvals for the specific manufacturing site and product is mandatory.
• Supply Chain Traceability: Implementing systems to track API from the manufacturing site to the finished product ensures transparency and accountability.

Cost and Pricing Factors

The price of Ibuprofen Sodium API is influenced by several factors:

• Raw Material Costs: The cost of key precursors, such as isobutylbenzene and acetic anhydride, directly impacts API pricing. Fluctuations in petrochemical markets affect these input costs.
• Manufacturing Costs: Labor, energy, regulatory compliance, and R&D investments contribute to the overall manufacturing cost.
• Production Volume and Scale: Larger production volumes typically lead to lower per-unit costs due to economies of scale.
• Market Demand: High demand relative to supply can drive up prices, while oversupply can lead to price erosion.
• Currency Exchange Rates: For international transactions, currency fluctuations can significantly alter the effective cost of the API.

Alternative Sourcing Strategies

To mitigate supply chain risks and ensure competitive pricing, pharmaceutical companies may adopt several sourcing strategies:

• Dual Sourcing: Qualifying and maintaining relationships with at least two approved suppliers, preferably from different geographical regions, can provide a buffer against disruptions.
• Long-Term Contracts: Negotiating long-term supply agreements can secure pricing and guaranteed supply volumes, though it may reduce flexibility.
• Regional Sourcing: Exploring API manufacturers in regions closer to the finished product manufacturing sites can reduce lead times and shipping costs, although this may be limited by the availability of qualified suppliers for Ibuprofen Sodium.
• Vertical Integration: In some cases, large pharmaceutical companies may consider backward integration into API manufacturing or strategic partnerships with API producers.

Future Trends in Ibuprofen Sodium API Sourcing

The landscape of API sourcing is continuously evolving. Key trends impacting Ibuprofen Sodium API include:

• Increased Regulatory Scrutiny: Health authorities worldwide are intensifying their oversight of API manufacturing and supply chains, demanding greater transparency and higher quality standards.
• Supply Chain Resilience Initiatives: Companies are increasingly focused on building more robust and resilient supply chains, with an emphasis on diversification and risk assessment.
• Sustainability in Manufacturing: Growing pressure for environmentally responsible manufacturing practices may lead to shifts in production methods and supplier selection criteria.
• Technological Advancements: Innovations in continuous manufacturing and process analytical technology (PAT) could enhance API production efficiency and quality control.

Key Takeaways

• The global supply of Ibuprofen Sodium API is dominated by manufacturers in China and India, with established players also present in Europe.
• IOL Chemicals and Pharmaceuticals Ltd. (India) is a prominent producer with significant capacity.
• Supply chain risks include geopolitical factors, regulatory changes, environmental compliance, and logistics disruptions.
• Robust quality control, including supplier audits and independent batch testing, is essential.
• Pricing is influenced by raw material costs, manufacturing expenses, and market demand.
• Dual sourcing and long-term contracts are key strategies for risk mitigation.
• Future trends point towards increased regulatory scrutiny, supply chain resilience, and sustainability.

Frequently Asked Questions

What are the primary pharmacopeial standards for Ibuprofen Sodium API?

The primary pharmacopeial standards for Ibuprofen Sodium API are the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP). These monographs define purity limits, identification tests, assay requirements, and limits for impurities such as residual solvents and heavy metals.

How does Ibuprofen Sodium differ from Ibuprofen Acid in terms of API sourcing?

While both are forms of ibuprofen, sourcing considerations can differ. Ibuprofen Sodium's solubility advantage often makes it preferred for certain rapid-release formulations. API manufacturers may specialize in one form or produce both. Sourcing Ibuprofen Sodium requires verifying that the manufacturer's processes are optimized for salt formation and stability, meeting specific pharmacopeial requirements for the sodium salt.

What is the typical lead time for sourcing bulk Ibuprofen Sodium API?

Typical lead times for bulk Ibuprofen Sodium API can range from 4 to 12 weeks, depending on the supplier's current inventory, production schedules, order volume, and shipping logistics. For new suppliers or large quantities, the lead time may extend to accommodate production and qualification processes.

What are the implications of GMP compliance for an Ibuprofen Sodium API supplier?

Good Manufacturing Practices (GMP) compliance is a mandatory requirement for all API suppliers. For Ibuprofen Sodium API, GMP ensures that the drug is consistently produced and controlled according to quality standards. This includes aspects of:

• Facility and Equipment: Proper design, maintenance, and cleaning.
• Personnel: Adequate training and hygiene.
• Raw Material Control: Testing and proper storage.
• Process Validation: Ensuring manufacturing processes consistently yield product meeting specifications.
• Quality Control: Testing at various stages and final product release.
• Documentation: Comprehensive record-keeping for traceability. Failure to comply can result in product recalls, regulatory sanctions, and inability to supply to regulated markets.

Can a single manufacturer guarantee supply chain security for Ibuprofen Sodium API?

No single manufacturer can guarantee absolute supply chain security. While reputable manufacturers strive for reliability, external factors such as natural disasters, geopolitical events, regulatory changes, or unforeseen production issues can impact any supplier. Diversifying the supplier base across different geographical regions and maintaining strong relationships with multiple qualified vendors are critical for mitigating these risks.

---

Citations

[1] United States Pharmacopeial Convention. (n.d.). United States Pharmacopeia. Retrieved from https://www.usp.org/ [2] European Directorate for the Quality of Medicines & HealthCare. (n.d.). European Pharmacopoeia. Retrieved from https://www.edqm.eu/ [3] Japanese Pharmacopoeia. (n.d.). Japanese Pharmacopoeia. Retrieved from https://www.pmda.go.jp/english/ [4] IOL Chemicals and Pharmaceuticals Ltd. (n.d.). Product Portfolio. Retrieved from https://www.iolcp.com/ (Note: Specific capacity figures are proprietary and not publicly disclosed in detail. Information is based on industry reports and company statements). [5] Qilu Pharmaceutical Co., Ltd. (n.d.). APIs. Retrieved from https://www.qilu-pharma.com/ (Note: General company information and API focus). [6] Hengdian Group. (n.d.). Pharmaceuticals. Retrieved from https://www.hengdiangroup.com/ (Note: General company information and API focus). [7] Zhejiang NHU Co., Ltd. (n.d.). API Products. Retrieved from https://www.tianrui-pharma.com/ (Note: Often operates under subsidiaries; this reflects a parent/related entity presence). [8] Granules India Ltd. (n.d.). API Products. Retrieved from https://www.granulesindia.com/ [9] BASF SE. (n.d.). Pharmaceutical Ingredients. Retrieved from https://www.basf.com/ (Note: Primarily known for ibuprofen acid; potential for broader involvement). [10] Recordati S.p.A. (n.d.). API Manufacturing. Retrieved from https://www.recordati.com/